CVRx/CVRX

13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1YMAX

About CVRx

CVRx, Inc. is a commercial-stage medical device company. The Company is focused on developing, manufacturing and commercializing advanced neuromodulation solutions for patients with cardiovascular diseases. The Company's integrated platform technology, Barostim, is designed to leverage the power of the brain and nervous system to address the imbalance of the autonomic nervous system (ANS), which causes heart failure with reduced ejection fraction (HFrEF) and other cardiovascular diseases. Barostim provides Baroreflex Activation Therapy (BAT) by sending imperceptible and persistent electrical pulses to baroreceptors located in the wall of the carotid artery to signal the brain to modulate cardiovascular function. Barostim is a minimally invasive neuromodulation device that consists of two implantable components, an implantable pulse generator (IPG) and a stimulation lead, and is programed by a wireless clinician-controlled programmer that communicates with the IPG.

Ticker

CVRX

Sector

Healthcare

Trading on

NASDAQ

Industry

Medical Equipment & Supplies

CEO

Kevin Hykes

Employees

200

Headquarters

Minneapolis, United States

CVRx Metrics

BasicAdvanced
$150M
Market cap
-
P/E ratio
-$2.48
EPS
-
Beta
-
Dividend rate
$150M
$33.14
$6.66
221K
12.184
10.868
44.174
44.174
-21.11%
-45.45%
-62.70%
-48.95%
3.566
2.265
2.265
59.59%
-19.32%
86.55%

What the Analysts think about CVRx

Analyst Ratings

Majority rating from 6 analysts.
Buy

CVRx Financial Performance

Income StatementBalance sheetCash Flow

Income Statement

Revenues and expenses
-206.54% profit margin
QuarterlyAnnual
Q1 24
QoQ growth
Revenue
$11M
-5.31%
Net income
-$22M
142.86%
Profit margin
-206.54%
156.48%

CVRx Earnings Performance

Earnings per share (EPS)

Company profitability
Missed by 92.30%
QuarterlyAnnual
Q2 23
Q3 23
Q4 23
Q1 24
Q2 24
Actual
-$0.56
-$0.43
-$0.44
-$1.04
-
Expected
-$0.58
-$0.58
-$0.54
-$0.54
-$0.55
Surprise
-4.00%
-25.65%
-19.24%
92.30%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. Fundamental data, financials and analyst ratings are sourced from Refinitiv.
Market closedNon-fractional

Upcoming events

No upcoming events

FAQs

What’s the current market cap for CVRx stock?

CVRx (CVRX) has a market cap of $150M as of June 20, 2024.

What is the P/E ratio for CVRx stock?

The price to earnings (P/E) ratio for CVRx (CVRX) stock is 0 as of June 20, 2024.

Does CVRx stock pay dividends?

No, CVRx (CVRX) stock does not pay dividends to its shareholders as of June 20, 2024.

When is the next CVRx dividend payment date?

CVRx (CVRX) stock does not pay dividends to its shareholders.

What is the beta indicator for CVRx?

CVRx (CVRX) does not currently have a Beta indicator.

What is the CVRx stock price target?

The target price for CVRx (CVRX) stock is $17.5, which is NaN% below the current price of $. This is an average based on projections from 4 analysts, and represents their view of what the stock price could be in 12 or 18 months. This should not be seen as investment advice - Lightyear does not carry out investment research.

Buy or sell CVRx stock

Buy or sell CVRx stock

Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.
Start investing